NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 118 filers reported holding NOVAVAX INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $912 | -2.6% | 126 | 0.0% | 0.00% | – |
| Q2 2023 | $936 | +7.2% | 126 | 0.0% | 0.00% | – |
| Q1 2023 | $873 | -32.6% | 126 | 0.0% | 0.00% | – |
| Q4 2022 | $1,295 | -35.2% | 126 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -66.7% | 126 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -33.3% | 126 | +0.8% | 0.00% | – |
| Q1 2022 | $9,000 | -50.0% | 125 | 0.0% | 0.00% | – |
| Q4 2021 | $18,000 | -30.8% | 125 | 0.0% | 0.00% | – |
| Q3 2021 | $26,000 | -3.7% | 125 | 0.0% | 0.00% | – |
| Q2 2021 | $27,000 | +17.4% | 125 | 0.0% | 0.00% | – |
| Q1 2021 | $23,000 | +64.3% | 125 | 0.0% | 0.00% | – |
| Q4 2020 | $14,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q3 2020 | $14,000 | +40.0% | 125 | 0.0% | 0.00% | – |
| Q2 2020 | $10,000 | +400.0% | 125 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 125 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 125 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |